247 results on '"Nakashima, Taku"'
Search Results
2. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis
3. Lung cancer with comorbid interstitial pneumonia: Current situation and animal model development
4. Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
5. Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial–mesenchymal transition in lung endothelial cells
6. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality
7. Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in Japan
8. Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy
9. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases
10. Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysis
11. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation
12. Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
13. Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
14. Extent of pulmonary fibrosis on high-resolution computed tomography is a prognostic factor in patients with pleuroparenchymal fibroelastosis
15. Pulmonary lymphangitic carcinomatosis from recurrent gastric cancer 19 years after primary resection: a case report
16. Concomitant emphysema might increase the false-negative rate of urinary antigen tests in patients with pneumococcal pneumonia: results from a retrospective study
17. Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
18. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
19. Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
20. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis
21. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients
22. Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
23. Albumin–globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer
24. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer
25. Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia
26. Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals
27. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
28. Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reports
29. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer
30. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery
31. Intestinal overgrowth of Candida albicans exacerbates bleomycin‐induced pulmonary fibrosis in mice with dysbiosis.
32. Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis.
33. Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study
34. Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung
35. Clinically remitted childhood asthma is associated with airflow obstruction in middle‐aged adults
36. Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis.
37. Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition.
38. Mesenchymal-Specific Deletion of C/EBPβ Suppresses Pulmonary Fibrosis
39. Mucins Carrying Selectin Ligands as Predictive Biomarkers of Disseminated Intravascular Coagulation Complication in ARDS
40. Chronic Hepatitis C Virus Infection is Associated with More Severe Asthma
41. Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case report.
42. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model
43. Association Between Patient Preference for Inhaler Medications and Asthma Outcomes.
44. Vocal cord dysfunction detected by a three-dimensional image of dynamic change in respiratory resistance in a patient with difficult-to-treat asthma: a case report.
45. Increased of Receptor Type Tyrosine Kinase Ros1 in Interstitial Lung Disease: PS417
46. Bronchoalveolar Lavage Cellular Pattern Can Predict the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis: OS249
47. Comparison of KL-6, SP-A, SP-D, 8-Isoprostane, MMP-9, and TIMP-1 as Serum Biomarkers for Patients with Combined Pulmonary Fibrosis and Emphysema: OS180
48. Lung Bone Marrow-derived Hematopoietic Progenitor Cells Enhance Pulmonary Fibrosis
49. Essential role of stem cell factor–c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis
50. First‐line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptorG719S and de novo T790M mutations.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.